Adjuvant combinations of NKT activator, CD40 agonist, and optional antigen, the use through inducing synergistic cellular immunity

• 收藏
• 分享

专利权人:

Immurx; Inc.

发明人:

Noelle, Randolph,Ahonen, Cory

申请号：

AU2008246149

公开号：

AU2008246149B2

申请日:

2008.04.25

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

Adjuvant combinations comprising at least one NKT activator, such as alpha-galactosylceramide(α-Gal-Cer) or iGb3, a CD40 agonist and optionally an antigen are disclosed.The use of these immune adjuvants for treatment of various chronic diseases suchas cancers is also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/